The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.50
Bid: 12.00
Ask: 13.00
Change: 0.00 (0.00%)
Spread: 1.00 (8.333%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
SNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

10 Jan 2020 13:30

RNS Number : 4848Z
Sabien Technology Group PLC
10 January 2020
 

For immediate release

10 January 2020

Sabien Technology Group plc

("Sabien" or the "Company")

Issue of equity

The Board of Sabien is pleased to announce that the placing of 200,000,000 new ordinary shares (the "Placing Shares") with new and existing investors, at a price of 0.15 pence per Placing Share (the "Placing Price") was approved by shareholders at the General Meeting held on 8 January 2020 and the Placing Shares commenced trading on AIM with effect from 9 January 2020 (the "Placing").

As previously announced, the Company's largest shareholder, Truell Intergenerational Family Limited Partnership ("TIG"), subscribed for 20,000,000 Placing Shares at the Placing Price and is now interested in 316,751,623 ordinary shares representing 22.84 per cent. of the enlarged issued share capital. TIG had previously been interested in 25.0 per cent. of the Company's issued share capital and had expressed an interest to subscribe for further new ordinary shares at the Placing Price to maintain its interest at 25.0 per cent. The Board of Sabien has now agreed today to issue 46,666,667 new ordinary shares at the Placing Price to TIG ("Subscription"). Following completion of the Subscription and the further issue of equity set out below, TIG will be interested in 25.0 per cent. of the enlarged issued share capital.

The proceeds of the Subscription amount to £70,000 and will be used to provide additional working capital for the continued development of the Company, in line with its stated strategy. Together with existing cash balances (including the proceeds of the Placing) the Company's current cash balances will amount to approximately £820,000. In order to maximise the Company's cash funds available for new investment, the Board has also agreed today to settle accrued but unpaid directors fees due to Cédriane de Boucaud Truell and Marco Nijhof (amounting to £15,000 each) in new ordinary shares ("Fee Shares"), also to be issued at the Placing Price. Accordingly, the Board has issued 10,000,000 new ordinary shares to each of Cédriane de Boucaud Truell and Marco Nijhof (neither of whom previously held any ordinary shares), and who will each be interested in 0.69 per cent of the enlarged issued share capital of the Company.

Once issued, the Subscription Shares and the Fee Shares (together the "New Shares") will rank pari passu with the Company's existing ordinary shares. Application will be made for the New Shares to be admitted to trading on AIM ("Admission") on or around 16 January 2020. The New Shares in aggregate represent 4.8 per cent. of the current issued share capital of the Company.

Richard Parris said:

"These additional funds further strengthen the Company's position to respond to possible business opportunities and broadens the alignment of Directors interests with those of our shareholders."

Total Voting Rights

In conformity with the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority ("FCA") Sabien announces that as at today's date the Company's issued share capital consists of 1,453,673,157 Ordinary Shares of 0.01p each with voting rights. The Company does not hold any Ordinary Shares in Treasury. Therefore, the total number of Ordinary Shares in the Company with voting rights is 1,453,673,157.

The above figure of 1,453,673,157 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Special note concerning the Market Abuse Regulation

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014 ("MAR").

The person who arranged for the release of this announcement on behalf of the Company was Richard Parris, Executive Chairman.

For further information:

Sabien Technology Group plc

Richard Parris and Cédriane de Boucaud Truell

+44(0)20 7993 3700

Beaumont Cornish Limited (Nominated Advisor)

Michael Cornish and Roland Cornish

www.beaumontcornish.com

+44(0)20 7628 3396

Peterhouse Capital Limited (Broker)

Duncan Vasey and Lucy Williams

+44(0)20 7469 0930

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Cédriane de Boucaud Truell

2

 

Reason for the notification

 

a)

 

Position/status

 

Director

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Sabien Technology Group plc

b)

 

LEI

 

213800S5QG1SMGHFHY68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 0.01p each ("Ordinary Shares")

 

Identification code

ISIN: GB00B1FPCD38

 

b)

 

Nature of the transaction

 

Settlement of directors' fees in Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volumes(s)

£0.15

10,000,000

 

 

 

d)

 

Aggregated information

n/a

- Aggregated volume

- Price

e)

 

Date of the transaction

 

10 January 2019

f)

 

Place of the transaction

 

London Stock Exchange

XLON

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Marco Nijhof

2

 

Reason for the notification

 

a)

 

Position/status

 

Director

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Sabien Technology Group plc

b)

 

LEI

 

213800S5QG1SMGHFHY68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 0.01p each ("Ordinary Shares")

 

Identification code

ISIN: GB00B1FPCD38

 

b)

 

Nature of the transaction

 

Settlement of directors' fees in Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volumes(s)

£0.15

10,000,000

 

 

 

d)

 

Aggregated information

n/a

- Aggregated volume

- Price

e)

 

Date of the transaction

 

10 January 2019

f)

 

Place of the transaction

 

London Stock Exchange

XLON

 

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEKKKBDNBKDBDD
Date   Source Headline
26th Mar 20137:00 amRNSFireye Distributorship Agreement
12th Feb 20139:29 amRNSHolding(s) in Company
12th Feb 20137:00 amRNSHalf Yearly Report
6th Feb 20133:44 pmRNSHolding(s) in Company
6th Feb 20133:11 pmRNSChange of ACD for OEIC holding
31st Jan 201310:11 amRNSNotice of Results
22nd Nov 20127:00 amRNSAGM Statement
30th Oct 201210:44 amRNSGrant of share options
29th Oct 201210:19 amRNSDispatch of Annual Financial Report
17th Oct 20127:00 amRNSAppointment of Mrs Miriam Maes as a Director
1st Oct 20127:00 amRNSPreliminary Statement of Final Results
30th Aug 20122:30 pmRNSRetirement of Chairman
10th Jul 20127:00 amRNSPost Close Trading Statement
7th Mar 20127:00 amRNSRe Contract
7th Feb 20127:00 amRNSHalf Yearly Report
1st Feb 20127:00 amRNSRe-organisation of Nominated Adviser and Broker
12th Jan 201212:20 pmRNSDirector Declaration
12th Jan 20129:27 amRNSCapital Reorganisation
9th Jan 20127:00 amRNSNotice of Results
5th Jan 20127:00 amRNSChange of Adviser
19th Dec 201110:54 amRNSDirector Declaration
29th Nov 201110:19 amRNSHolding(s) in Company
24th Nov 20117:00 amRNSResult of AGM
21st Nov 201110:26 amRNSHolding(s) in Company
17th Nov 201111:23 amRNSHolding(s) in Company
4th Nov 20111:50 pmRNSHolding(s) in Company
1st Nov 20117:00 amRNSAnnual Report and Accounts
7th Oct 20117:00 amRNSNew Contract Win
3rd Oct 20117:00 amRNSFinal Results
12th Sep 20117:00 amRNSNew Contract Win
25th Aug 20117:00 amRNSNew Contract Win
11th Jul 20117:00 amRNSPost Year End Trading Update
29th Jun 20111:12 pmRNSM2G sale to US Distributor
2nd Jun 201112:15 pmRNSNotice of Results
8th Apr 201111:28 amRNSM2G sale to US Distributor
2nd Mar 201111:44 amRNSHolding(s) in Company
1st Mar 201111:08 amRNSHolding(s) in Company
7th Feb 20117:00 amRNSHalf Yearly Report
5th Jan 20117:00 amRNSNotice of Results and Trading Update
26th Nov 20107:00 amRNSDirector/PDMR Shareholding
25th Nov 20107:00 amRNSResult of AGM
17th Nov 20107:00 amRNSAward of Contract
12th Nov 20104:12 pmRNSAnnual Financial Report
29th Oct 20107:00 amRNSPreliminary Results
18th Oct 20107:00 amRNSNotice of Results
15th Oct 20107:00 amRNSDirectorate Change
20th Sep 20107:00 amRNSAward of Contract
6th Aug 20107:00 amRNSAward of Contract
5th Jul 20107:00 amRNSAward of Contract
24th Jun 20107:00 amRNSAward of Contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.